Overall Survival and Adjuvant Therapy in Women with Ovarian Carcinosarcoma: A Single-Institution Experience

Background: Carcinosarcoma of the ovary (CSO) is a rare and aggressive variant of ovarian cancer. Due to the rare nature of the disease there is insufficient evidence to make recommendations regarding standard management and overall prognosis. Methods: An Institutional Review Board-approved study id...

Descripción completa

Detalles Bibliográficos
Autores principales: Nizam, Aaron, Bustamante, Bethany, Shan, Weiwei, Shih, Karin K., Whyte, Jill S., Sakaris, Antoinette, dos Santos, Lisa, Frimer, Marina, Menzin, Andrew W., Truskinovsky, Alexander, Goldberg, Gary L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963805/
https://www.ncbi.nlm.nih.gov/pubmed/31766630
http://dx.doi.org/10.3390/diagnostics9040200

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963805/
https://www.ncbi.nlm.nih.gov/pubmed/31766630
http://dx.doi.org/10.3390/diagnostics9040200

Ejemplares similares